A Texas Democrat is urging the Trump administration to fund hormone drugs for illegal immigrants in federal detention, igniting a fresh fight over borders, budgets, and common sense.
Story Highlights
- Rep. Al Green pressed the Department of Homeland Security to restore transgender hormone treatments in Immigration and Customs Enforcement custody.
- Immigration and Customs Enforcement standards already say detainees on hormones before custody must have continued access based on medical need.
- Immigration and Customs Enforcement publicly stated it is not spending taxpayer funds on hormone therapy, according to reporting cited by The Washington Times.
- Human Rights Watch has noted Immigration and Customs Enforcement policy aligns with continued access for those already on treatment.
Democrat Pushes Taxpayer Coverage for Transgender Drugs in Detention
Rep. Al Green of Texas sent a September 4, 2026 letter to Homeland Security Secretary Markwayne Mullin. He claimed the federal government halted “specialized medical care” for transgender detainees at at least ten facilities. He urged the administration to restore hormones and related care while people are in Immigration and Customs Enforcement custody, framing the issue as a policy failure that risks harm to detainees. His public remarks renewed debate over priorities at the border during ongoing budget strain.
Rep. Green’s demand centers on restored access to hormone therapy and other gender-related services. He tied his appeal to conditions he said were caused by “deliberate agency policies.” He asked the Department of Homeland Security to direct Immigration and Customs Enforcement to change course and guarantee these treatments in detention. His letter cited potential health effects from stopping hormones. The request would shift more medical costs for noncitizens onto federal taxpayers during detention processing.
What Immigration and Customs Enforcement Policy Already Says
Immigration and Customs Enforcement performance standards state that transgender detainees already on hormone therapy “shall have continued access” when they enter custody. The standards also say all transgender detainees must have access to mental health care and other related medication based on medical need. The policy describes care by qualified medical professionals who assess each case. These written rules set a floor for care decisions across facilities under federal contracts.
Immigration and Customs Enforcement public materials echo those rules. An agency infographic says transgender detainees have continued access to mental and gender-affirming health care provided by qualified medical professionals. The document reinforces that care is based on clinical need, not political pressure. It also suggests the agency expects contractors to follow a consistent care model across detention sites. Human Rights Watch has described the written policy as aligning with continued access for those who were already on treatment before custody.
The Taxpayer Question and Conflicting Signals
The Washington Times reported that Immigration and Customs Enforcement told The New York Times, “We are NOT wasting U.S. taxpayer dollars to provide hormone therapy,” while also saying detainees were not abused or beaten. That statement sits in tension with Rep. Green’s push to fund and expand access. It also raises a key issue for voters: who pays, and under what rules, when noncitizens request gender-related drugs during detention processing and removal cases.
President Trump’s administration faces a choice. It can enforce the existing medical-need standard and prevent policy creep that turns detention into a new taxpayer health plan. Or it can accept Rep. Green’s framing and pour more federal dollars into elective gender care for people who crossed the border illegally. With inflation, high energy costs, and tight budgets, many Americans will ask why federal funds should cover hormones for detainees when veterans and families struggle for timely care.
Field Complaints Versus Written Standards
Advocates often argue that care on paper does not always match care on the ground. Some legal filings and reports describe gaps or delays in transgender-related care in detention settings. These accounts claim uneven practice, contractor errors, or weak oversight. But Immigration and Customs Enforcement standards remain clear on continued access for those already on treatment and medical-need assessments for others. The core dispute is not about whether a policy exists. It is about whether taxpayers should expand obligations beyond those standards.
For conservatives, the line is simple. The government must secure the border, enforce the law, and avoid turning detention into a taxpayer-funded clinic for elective care. Immigration and Customs Enforcement already promises clinically necessary treatment for those who arrive on hormones. Rep. Green wants more. The Trump administration can back the standards, tighten oversight so facilities follow them, and stop attempts to force taxpayers to bankroll new gender programs for people who broke our immigration laws.
Sources:
lifesitenews.com, lifezette.com, theblaze.com, algreen.house.gov, dhs.gov
